|
Items
|
Cox’s regression analysis
|
|---|
|
P value
|
HR
|
95%CI
|
|---|
|
Lower
|
Higher
|
|---|
|
Univariate Cox’s regression
|
|
Katanin P60 high
|
0.001
|
1.607
|
1.226
|
2.107
|
|
Age (> 60.0 years)
|
0.158
|
1.216
|
0.927
|
1.596
|
|
Male
|
0.757
|
1.053
|
0.758
|
1.464
|
|
History of smoke
|
0.844
|
0.973
|
0.744
|
1.274
|
|
History of drink
|
0.658
|
1.064
|
0.809
|
1.400
|
|
Hypertension
|
0.928
|
0.987
|
0.747
|
1.304
|
|
Hyperlipidemia
|
0.362
|
0.874
|
0.655
|
1.167
|
|
Diabetes
|
0.126
|
0.740
|
0.503
|
1.088
|
|
Higher pathological grade
|
0.061
|
1.218
|
0.991
|
1.498
|
|
Tumor size (> 5.0 cm)
|
0.018
|
1.389
|
1.059
|
1.823
|
|
LYN metastasis
|
< 0.001
|
2.565
|
1.943
|
3.388
|
|
Higher TNM stage
|
< 0.001
|
1.524
|
1.288
|
1.804
|
|
CEA abnormal (> 5.0 ng/mL)
|
0.011
|
1.420
|
1.084
|
1.860
|
|
Forward stepwise multivariate Cox’s regression
|
|
Katanin P60 high
|
0.002
|
1.527
|
1.161
|
2.010
|
|
LYN metastasis
|
< 0.001
|
2.395
|
1.809
|
3.169
|
|
CEA abnormal (> 5.0 ng/mL)
|
0.020
|
1.382
|
1.052
|
1.815
|
- DFS disease-free survival, HR hazard ratio, CI confidence interval, LYN lymph node, CEA carcinoembryonic antigen
